HD plasma exchange treatment of severe combined hyperlipidemia in 12 cases of pancreatitis Effect.docVIP

 PAGE \* MERGEFORMAT 7 HD plasma exchange treatment of severe combined hyperlipidemia in 12 cases of pancreatitis Effect [Abstract] Objective To observe hemodiafiltration combined with plasma exchange treatment of severe hyperlipidemic pancreatitis. Methods to select 12 patients with severe pancreatitis with hyperlipidemia were randomly divided into two groups: A group (n = 6 ) line of traditional pancreatitis, B group (n = 6) while the line hemodiafiltration combined plasma exchange treatment and hospitalization were compared (dialysis) after 48h APACHE score and recovery time of blood amylase, tumor necrosis factor - @ (TNF-@) and hospitalization (dialysis) 6 days after the above-mentioned indicators. Results B patients APACHE score, fasting time, hospitalization time, recovery time of urine amylase was less than A group (P all lt;0.05) . A, B After treatment, levels of serum TNF-@ were lower than those before treatment (P all lt;0.05), compared with A group and B group decreased significantly (P lt;0.05). Conclusion hemodiafiltration combined with plasma exchange is the treatment of severe hyperlipidemic pancreatitis preferred one of the options. [Keywords:] Hemodialysis, plasma exchange, hyperlipidemia, pancreatitis Acute pancreatitis is a common medical one. Overeating, alcoholism and cholelithiasis as the common causes, clinical treatment principles that guide public [1]. But severe hyperlipidemic pancreatitis is less common, the treatment are also different , July 2003 -2008 in July, I were treated with severe hyperlipidemic pancreatitis in 12 cases, reported as follows. 1 Subjects and methods 1.1 The subjects were 12 patients, median age 45 (35 ~ 67) years of age, are consistent with severe acute pancreatitis diagnostic criteria [2], white blood cell countgt; 15 109 / L, glucosegt; 11mmol / L, triglyceridesgt; 11.3 mmol / L, combined chest tightness, abdominal distension, abdominal pain, massive ascites, pleural effusion and liver and